With the recent approval of 18F-flortaucipir (previously called T807/AV-1451, trade name Tauvid; Lilly) for clinical use by the U.S. Food and Drug Administration, there is increasing excitement around tau imaging. 18F-flortaucipir PET is now approved to estimate the density and distribution of
No takes yet. Share an insight, caveat, or question.
Tanner et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: